TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Relative quantification of gut microbiota taxonomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Contractile performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Elevation of serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in MDS-UPDRS Part III score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in patient-reported motor symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minutes per day of moderate and vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes per day of light and sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Oxygen Consumption (Vo2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Composition Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Secure Flourish Measure (Adolescent Version)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Secure Flourish Measure (Adult Version)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Herth Hope Index Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perceived Social Support from Health Care Professionals
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Self-transcendence Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perfusion defect prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mental symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity and specificity of the screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of the cfDNA methylation-based model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability and Validity of TESS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Ascending Aortic Pulse Wave Velocity (AA PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Carotid and Femoral Artery Pulse Wave Velocity (CF-PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Carotid and Radial Artery Pulse Wave Velocity (CR-PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hazelbaker scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latch Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical jump measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyographical activity (EMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal pressure gradient measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hepatic venous pressure gradient measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Quality of Life Short Form 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to stable liquid culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Functional Ambulation Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (Visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: praxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social functionality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of prisoners treated for HCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dual task performance after muscular fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual task performance after cognitive fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Malondialdehyde (MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sore throat 24 hours postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 60-day Obstruction Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability assessed by VAS scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient tolerance assessed by QoL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neurodegeneration correlation with Nfl levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time for long read human genome sequencing and data interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nail Thickness Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Engagement with the Produce Prescription Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Intervention Measure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Beck Anxiety Inventory's score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with ≥75% improvement in PASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neutralizing Antibody Titers Against RSV A Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: First Occurrence of RT-PCR confirmed RSV Mediated-lower Respiratory Tract Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total number of recurrent mood episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of mood episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total points of Pain Related Avoidance of Movement Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Procrastination measured by Pure Procrastination Scale (PPS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Positive and Negative Affect Schedule questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parenting Sense of Competence questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of microplastics in human granulosa cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of microplastics in the Follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful Completion of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain-Related Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of SCD-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Unanticipated Adverse Device Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Reward responsiveness immediately post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward sensitivity immediately post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive functioning (task-switching total incorrect)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Action Research Arm Test (ARAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV and stress index pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine-induced immunity (status and durability) against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: General health status (physical, mental, social)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: labs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Adverse Cardiac and Cerebrovascular events (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 40Hz Auditory steady state response (ASSR) EEG power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Same Day Discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Generic Questionnaire SF-12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Specific questionnaire QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: myometrial thickness in supracervical area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insula synaptic density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking self-administration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Insula-centric functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of dialysis related bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Anxiety levels in intensive care patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient completion of surveillance tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Drinks per Drinking Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancelled unnecessary scheduled ECV appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of surgical guile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Marginal bone levels changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstructive Apnea-Hypopnea Index (oAHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Apnea-Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: minimum Oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of any additional Nd:YAG laser treatments beyond the initial Nd:YAG laser treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of Secondary Surgical Interventions (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of subjective visual disturbances per the Quality of Vision (QoV) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mean headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observer overall opinion of POSAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of the Fuster-BEWAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Downsizing of the largest nodule diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower-body muscular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in RBANS Total Scale Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Age-group based ratio of plasma PK parameter, area under the concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age-group based ratio of plasma PK parameter, apparent clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline to Week 2, 4, and 12 in resting state EEG power in the beta band
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to first occurrence of a CV death
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of a HF event
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of MI, stroke, or arterial revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of days covered with asthma biologics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain Catastrophizing Scale for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain Catastrophizing Scale for Parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RAD51 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin resistance measured by HOMA-IR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anesthetic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Infection rate after TEVAR
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of middle ear effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: Change from baseline in monthly migraine days (MMD) or monthly headache days (MHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral autoregulation parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional Well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in the rate of rebound pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day ICU-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Time delay for diagnosis of inflammatory bowel disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall Quality of Vision Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Long Covid
Endpoint domain: Adverse events/effects
Primary endpoint: A1-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of physical complications post-decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of reintubation post-decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of recannulation post-decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of death post-decannulation
Endpoint domain: Mortality/survival
Primary endpoint: Total time to successful lung isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of the AVEIR VR LP device and/or an AR LP device
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of the AVEIR VR LP device and/or an AR LP device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuroinflammation measured by activated brain microglia/macrophages concentration and distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clot Stability to Lysis (CSL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fibrinogen Contribution (FCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet Contribution (PCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clot Stiffness (CS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clot Time (CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dose of morphine used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in corneal indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Fibroblast Products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: percentage of SLE patients with premature atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of hyperuricemic patients with premature atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Range of Motion in knee joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Success Rate of Real-Time Circulating Tumor DNA (ctDNA) Sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Moderate to severe HIE
Endpoint domain: Mortality/survival
Primary endpoint: Change in Visual Acuity (VM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hematological Measurements (HM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Amsler Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility of brain CEUS examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of brain CEUS examinations
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate for leptomeningeal metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cancer detection rate (CDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibodies to B.1.351 variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects achieving seroconversion of SARS-CoV-2 neutralising antibodies to B.1.351 variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean fold rise (GMFR) of SARS-Cov-2 neutralising antibodies to B.1.351 variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compliance as measured by the self-reported volume of ketone supplement drink consumed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention as measured by the number of participants that complete the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alignment axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in M-value in hyperinsulinaemic euglycaemic clamp (HEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute bioavailability (F) of Saruparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total radioactivity recovery in urine and faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK parameters characterized by AUCinf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Nicotine (ng/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stair Assessment Index (SAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hill Assessment Index (SAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of ET-plus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving at Least a 75% Reduction in Eczema Area and Severity Index Score (EASI 75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Reported Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid Use in Morphine Milligram Equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functioning anastomosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: no occurrence of adverse events related to device use
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Serious and Non-serious Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Clinically Significant Laboratory Abnormalities or Changes in Laboratory Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Treatment-emergent Adverse Events Leading to the Discontinuation of Ferric Citrate
Endpoint domain: Adverse events/effects
Primary endpoint: Achilles tendon Total rupture score (ATRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes Toward Seeking Professional Psychological Help
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status